Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1121 | 991 | 1121 | 1049 | 1291 | 1634 |
Fund Return | 12.05% | -0.92% | 12.05% | 1.61% | 5.25% | 5.03% |
Place in category | 147 | 194 | 147 | 223 | 141 | 88 |
% in Category | 31 | 41 | 31 | 56 | 51 | 57 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech B USD | 1.68B | 8.05 | -2.31 | 8.95 | ||
Adamant Medtech I USD | 1.68B | 8.81 | -1.62 | 9.73 | ||
EDM Intl S American Growth A USD | 323.43M | 16.42 | -2.50 | 11.74 | ||
LU1811047247 | 314.36M | 4.69 | -10.13 | - | ||
LU1811047593 | 314.36M | 3.96 | -10.76 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
First Eagle Amundi Intl Fund Classr | 6.46B | 14.39 | 7.22 | 5.89 | ||
First Eagle Amundi Intl Fund Classc | 6.46B | 10.84 | 5.00 | 6.08 | ||
LU0068578508 | 6.46B | 9.64 | 3.87 | 4.98 | ||
First Eagle Amundi Intl Fund Classx | 6.46B | 10.32 | 4.49 | 5.82 | ||
First Eagle Amundi International Fq | 6.46B | 10.43 | 4.60 | 5.52 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
db x-trackers S&P 500 UCITS 1C | LU0490618542 | 17.73 | 9,776.0 | +1.28% | |
ASHBURTON INVESTMENTS SICAV GBL EQTY GRW FD C USD | - | 13.92 | - | - | |
iShares Core S&P 500 UCITS | IE00B5BMR087 | 10.38 | 648.42 | +1.05% | |
Ashburton Global Leaders Equity Fund C USD Acc | LU0923646664 | 9.09 | 22.813 | +0.97% | |
iShares MSCI ACWI UCITS | IE00B6R52259 | 6.35 | 92.59 | +0.71% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review